Metropolis Healthcare Limited (METROPOLIS) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.091x

Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) has a cash flow conversion efficiency ratio of 0.091x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.32 Billion ≈ $14.25 Million USD) by net assets (Rs14.43 Billion ≈ $156.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check Metropolis Healthcare Limited strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Metropolis Healthcare Limited - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Metropolis Healthcare Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. See METROPOLIS net assets for net asset value and shareholders' equity analysis.

Metropolis Healthcare Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Metropolis Healthcare Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ssangyong Information & Communications Corp KQ:010280	0.172x
Zippy Technology Corp TW:2420	0.059x
enCore Energy Corp. V:EU	0.050x
Autosports Group Ltd AU:ASG	0.043x
Fujian Yongan Forestry Group Joint-Stock SHE:000663	-0.020x
Promotora Ambiental S.A.B. de C.V MX:PASAB	0.211x
Shanghai Rendu Biotechnology Co. Ltd. A SHG:688193	N/A
Shanghai Challenge Textile Co Ltd SHE:002486	0.068x

Annual Cash Flow Conversion Efficiency for Metropolis Healthcare Limited (2014–2025)

The table below shows the annual cash flow conversion efficiency of Metropolis Healthcare Limited from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Metropolis Healthcare Limited worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs13.35 Billion ≈ $144.34 Million	Rs2.63 Billion ≈ $28.41 Million	0.197x	-18.05%
2024-03-31	Rs10.99 Billion ≈ $118.88 Million	Rs2.64 Billion ≈ $28.56 Million	0.240x	-3.68%
2023-03-31	Rs9.91 Billion ≈ $107.14 Million	Rs2.47 Billion ≈ $26.72 Million	0.249x	-12.54%
2022-03-31	Rs8.88 Billion ≈ $96.05 Million	Rs2.53 Billion ≈ $27.39 Million	0.285x	-18.92%
2021-03-31	Rs7.08 Billion ≈ $76.57 Million	Rs2.49 Billion ≈ $26.93 Million	0.352x	-14.09%
2020-03-31	Rs5.25 Billion ≈ $56.79 Million	Rs2.15 Billion ≈ $23.25 Million	0.409x	+90.72%
2019-03-31	Rs4.20 Billion ≈ $45.42 Million	Rs901.51 Million ≈ $9.75 Million	0.215x	-11.37%
2018-03-31	Rs4.29 Billion ≈ $46.41 Million	Rs1.04 Billion ≈ $11.24 Million	0.242x	-18.09%
2017-03-31	Rs3.44 Billion ≈ $37.22 Million	Rs1.02 Billion ≈ $11.00 Million	0.296x	-4.95%
2016-03-31	Rs2.94 Billion ≈ $31.78 Million	Rs914.16 Million ≈ $9.89 Million	0.311x	+72.03%
2015-03-31	Rs3.84 Billion ≈ $41.56 Million	Rs694.91 Million ≈ $7.52 Million	0.181x	-25.29%
2014-03-31	Rs3.18 Billion ≈ $34.37 Million	Rs769.22 Million ≈ $8.32 Million	0.242x	--

About Metropolis Healthcare Limited

NSE:METROPOLIS India Diagnostics & Research

Market Cap

$300.54 Million

Rs27.79 Billion INR

Market Cap Rank

#15026 Global

#736 in India

Share Price

Rs536.15

Change (1 day)

-0.87%

52-Week Range

Rs421.75 - Rs2236.70

All Time High

Rs3431.71